Pancreatic Cancer Research Consortium:
Genetic Approaches to Therapeutic Targets in Pancreatic Cancer
Gregory J. Hannon, Ph.D.
Investigator, Howard Hughes Medical Institute
Professor, Cold Spring Harbor Laboratory
Collaborating PCRC Member Institution
The University of Texas M.D. Anderson Cancer Center
This project will identify targets for new drug therapies based on genetic analysis. The research will combine comprehensive RNAi screening with pre-clinical studies in mouse models to identify genetic vulnerabilities in pancreatic cancer cells, making them promising targets for therapy.
back to PCRC